Skip to content

Epidemiology Study of Keloid

Epidemiology Study of Keloid

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01423383
Enrollment
100000
Registered
2011-08-25
Start date
2011-09-30
Completion date
2021-12-31
Last updated
2016-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid

Keywords

Keloid

Brief summary

Although keloid is a very common condition; there are no statistics as to its true incidence and prevalence, neither in United States, nor elsewhere in the world. This trial intends to capture epidemiological data about this disease in a large population sample.

Detailed description

The purpose of current trial is to establish a robust database of incidence and prevalence of keloid, as well as prevalence of familial keloid, in various ethnic groups. Study sample size is 100,000 random individuals who will fill out either a web survery or a paper questionnaire.

Interventions

None listed

Sponsors

Tirgan, Michael H., M.D.
Lead SponsorINDIV

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Informed consent 2. Age above 18 to answer the survey questions 3. Parents shall respond on behalf of their minor children

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of various clinical findings will be determined at the end of Survey.Two YearsThis will be a prospective online and paper based survey with an estimated 100,000 responders participating in two years. Statistics will be descriptive. The prevalence of various clinical findings will be determined at the end of Survey. Findings will be correlated with the source of the data, online, or paper questionnaire, as well as the locations where the paper questionnaires surveys were placed.

Countries

United States

Contacts

Primary ContactMichael H. Tirgan, MD
htirgan@aol.com(212) 874 4200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026